{"ticker": {"uuid": "d8a518cd-faae-411d-9e51-ae691d378355", "symbol": "BIIB", "name": "Biogen Inc.", "exchange": "VIE", "country": "AT", "sector": "Healthcare", "industry": "Drug Manufacturers - General"}, "articles": [{"title": "Biogen Shares Decline After Detailed Diranersen Alzheimer's Study Data", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxOVVR5dEN4SnN0MHpFOGNsMUZzWmhwWXpidnl5c0N1c1lTaWNoNTBoeGFNMjZzZ1dfZXdoME5GOUM2eW5SdENiRTVDVElCeG5ZUkJ0NTN4S3plWXhHQ3dHZDRZa0hBdEVtVmlTc0wyS1dhNnVSbFBiZXRJNng4NFBzQWV5ai1SRTg1SUJDaWJNdnQ5NVVv?oc=5", "source_name": "Yahoo! Finance Canada", "published_at": "2026-07-15T14:51:00+00:00", "published_display": "15 Jul 2026 14:51", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen's incoming legal chief has 20 years in biotech leadership", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxOUnRIeGp1NHc0X0U4U29lRGp5UHZBMUJ5NWJIamVEZVNfUjMtZ2FFUHROM0Z3ZlZIajZ1OUh3dXFQZDRkcERVRDJYVnhfYWp2cnNDTVotVE1wdW1BQkhTUk1PV3l2bzQ2akZLSThnVGhfZEY3WnRtRGkzNmUzZ296cE1zRS0wQ2MyZ0Z6QUNxZWpSTG5uelBqc0xVVkpsak9qdzRJNw?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-15T12:15:00+00:00", "published_display": "15 Jul 2026 12:15", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AAIC26: Biogen stock drops after unveiling tau-targeting ASO data", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxPQWRsTVNULWt1Y2Q0RVFPNmktOFFFLXhiYkdyeGJLeTBMcDhwMVViMnNjbWFzbF9Yc3lfTnVnVENFeVc4cjNzSmhYMTVsX1lTcFoyNTNVd19YY1BKZDRZSlVJOXdtVEs1dVBSNFY2aUR4R21nY0ZIT0k5a1MzTmIxM0dHbWxTMGRsVmdvWVBkVjhSdE5kbU93UDRuWl9BZXBBNS0tLXdOTHNtdw?oc=5", "source_name": "Clinical Trials Arena", "published_at": "2026-07-15T10:38:07+00:00", "published_display": "15 Jul 2026 10:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen (BIIB) Following Fresh Alzheimer\u2019s Data Is The Upside Story Still Intact", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxONk5GX0ZoNHhUVFNpb0hlRmEyRHY1UC1xUjl2ZFBidUxKNW1zTTRJckdsbzlDMU5VNlNkcHdKM19KcURzMzRDZzU1enJTcEo2ckJRTjhpSERaVmlVWmFYeWlOWVBFSXU5ZFFoSHBCZzhlLXNqYmNKUVBqN2cyQWx1RmdaZmJ3dWhFU3NoZUFfeVFYek5IM3NTS0cxaTRtaGphTl9BVw?oc=5", "source_name": "Market source", "published_at": "2026-07-15T02:11:00+00:00", "published_display": "15 Jul 2026 02:11", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen Dips As Questions Weigh On Alzheimer's 'Breakthrough'", "summary": "", "url": "https://news.google.com/rss/articles/CBMilgFBVV95cUxPVDB3YXIwcWpmMUpkUGJ4bGhQQ05HWjJIZi16RmFLeEN3UW1nTmhmV2RVUjdmWko0VWhwaGlqYXpHbjU2RzdndUdiN2R5UVVxc1VoRXU4YWs1SDZSQnhHUGQyem1xalZiX2RxcGtMU3M4aE9SMnhQQktNMGU4Q2pqRmxPbERDdTYzMC1Bc1hyYklQSGJHNFE?oc=5", "source_name": "Investor's Business Daily", "published_at": "2026-07-14T20:13:00+00:00", "published_display": "14 Jul 2026 20:13", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen\u2019s Alzheimer\u2019s Drug Leaves Questions Unanswered, and That\u2019s a Problem", "summary": "", "url": "https://news.google.com/rss/articles/CBMiekFVX3lxTFA3VFNGa2ZadVdpZmNTSkdPcy1IdUR3Rl9SOHhEM1VRbTJsVFdfUi1EdUw1Z2IyZ1JyTWtGa0ZZTFU2b3ZueTlISU83NXFReDkwMWVvN2Q5REJKRjdoSUVFc2tNUDg2Y29sWVpCbzVRVXJCb3JhdmhvLVZ3?oc=5", "source_name": "Barron's", "published_at": "2026-07-14T18:09:00+00:00", "published_display": "14 Jul 2026 18:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen defends anti-tau drug after stock slides on Alzheimer\u2019s readout", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxNSW45Q216RDR0VU1LTmgzRXF2M1BEdVExcGZhVDBDWlQzNHVVLXpNYmRtRHFGZkJPZGJxc3gzQkpQSzE1eldnUE5xdGUyMkE4RkxvdEl6aHBfNFMweUV5RTI5OWNzcHNzQUNWNGJLaTRyZllYblBJQmQtZzUzVzh3YWF5Ry1xSjV5azhfNmhoREdVdk8wRk8zaFZTZTZIRUk2Mm5IeUYyYw?oc=5", "source_name": "Fierce Biotech", "published_at": "2026-07-14T18:00:18+00:00", "published_display": "14 Jul 2026 18:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen stock falls 8% on Alzheimer's drug diranersen trial data", "summary": "", "url": "https://news.google.com/rss/articles/CBMifEFVX3lxTE4yZE1lckJXYnZXWjd0T2FvU0h6LWNRcEZMUXgtOFRkYktxRFg4NVJqYTJxMjk1eE81b0Z4dW83cDFLN2Fsa1lFLWQ2Q0JHdmg3R0pjZng3a1p2YWZOR0pmSVQwT1N5dHNrbkVkeEMtTnJXalhGUVQ3RlFvMUM?oc=5", "source_name": "qz.com", "published_at": "2026-07-14T17:42:38+00:00", "published_display": "14 Jul 2026 17:42", "sentiment": "negative", "sentiment_pct": 22, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen slides as investors reassess Alzheimer\u2019s data and earnings overhang", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxQZzdxemtVY2FSQXpyalFTX1YxaVpEUE9BOGpvR2xQN2MtcXRrcVQ4eVRLcjE3eXZfd05WRTd2aWxtMlQ2R3ZwVUczWm1VcnFEdnlfX3ZvNEpfNk56Y19BaWlGNnhubmV2TVdTZXNCQ3BHdHFSdEh5R1FFRzNWY29IUWxZMXJlM0JiUHNVMnNxcVdXVWxPSE50ZVpzVHVIanJEMXZfd0dBcE9IeTJUcElOWVhMdkdmUQ?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-07-14T14:51:00+00:00", "published_display": "14 Jul 2026 14:51", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How Investors Are Reacting To Biogen (BIIB) At-Home LEQEMBI Autoinjector Approval", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOVUZIWjNnSWJNTFFlaGlKTmh2LVp5ZjlSM0t0TE1ORFVjYVFXalN0V2NuWEIxcHNfMXllbFpNeDFTeVBVWmZTQ1pGUFhnV3M5R01GbU80NFRCdVlaQVJHcUtlNUkyYXlhRmJEdGxpaG9pRGVNZ1V0czUycE9JWmU0M3BDRml0N1VZNlJoSGhxR2VmWmlWS0EtalUtbVI?oc=5", "source_name": "Market source", "published_at": "2026-07-14T14:14:39+00:00", "published_display": "14 Jul 2026 14:14", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen Shares Rise After Positive Phase 2 Alzheimer\u2019s Trial Results (BIIB)", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxQLWpoTm14djJ1V2JHV1hxQlNoZUwtRjV0V2pOOFBIb2haNEU4TW5QdUg5TUhQb180bWxFczdYcWZScHF2Yk4zVHVIYUlIY3Q2Y2VHamJQWnl6QVh1YnVvb2JUNXFvSW4taTRvWl9jR3BMY0JiRjNYQWMyT3VSUnBhSkl5S05TeUhteTdialVBdl9CbFF3b0ZxVkxR?oc=5", "source_name": "Market source", "published_at": "2026-07-14T13:48:37+00:00", "published_display": "14 Jul 2026 13:48", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen Stock Is Upgraded to Buy Ahead of Key Alzheimer\u2019s Drug Study Details", "summary": "", "url": "https://news.google.com/rss/articles/CBMigwFBVV95cUxONlozWDZQcXFxdjFmVEJvWEE2M0p4OUFKX2FsOEFSalB1RnRsVXFxa0dSenNGMmFaMzQxakRFQVB0eERMXzU4UlVpNkQ1WWRzc0hDZk9WQ1o4NkhlUlBhUVZkMm85Wl9TMGM2T3lCeEdUekVJUHZ0Z2t5WGh3V0FqRjgzbw?oc=5", "source_name": "Barron's", "published_at": "2026-07-13T18:32:00+00:00", "published_display": "13 Jul 2026 18:32", "sentiment": "positive", "sentiment_pct": 84, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Here is Why Biogen (BIIB) is One of the Most Undervalued NASDAQ Stocks to Buy Right Now", "summary": "", "url": "https://news.google.com/rss/articles/CBMikwFBVV95cUxNR1huQlhQV3dTUFFGeXMxMFBOVkc3aXhaYUhscUhUdE9UQTRSVk9CNGtDRGFhcTQyYlowbXdiNUR2RGdDczNMZXdwblR5OFdNNk04cjRLUkR3cXN4MXhKVG1RWXYtT1NTb2V6d2JiMzF6dndGX194alkwZGw4UjdubUxkWXpuM0E1MEZIVXo3SlFvWlE?oc=5", "source_name": "Market source", "published_at": "2026-07-05T07:00:00+00:00", "published_display": "05 Jul 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Biogen (BIIB) Stock Is Up Today", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxPbmNGeFAtenBxazFmYWJoYzFSd2tSRDRHa3J2S1F6SVdKRkFxTzY1WlFxeFg0TV9VYzBBdk54MmtBUFhNY211enhVSGUxeTczMURlUEktTmVpLUVDUUFDRzNBT2pWUFdVRUlCT3U0VHVfYjMxZUs1bW4xeWJTU2hXUURrTG9EaGdnbGU4N0hJNHVxb3l5UUFn?oc=5", "source_name": "Market source", "published_at": "2026-06-26T07:00:00+00:00", "published_display": "26 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen stock price forecast: $174.41 support comes into view as BIIB slips 1.94%", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxQamVtNDJibjVtbWNGNEdPWG1QajFFcUR6cmlUYWNRWmQzUnRaMHd2WFNmYlZDSGN0b011SHlqUG1rN25sSmlfWTRTeXM0Q1RHTXVBZGtMbC1ab1NOSGRvdlp4VlJrMjU0ZUFObTlTMFM4SVlxbjZYSFVycFlpOFlRb2R6d0lac2pXTHE2T3RwRmlOOEp5cGNCTnZfeExudw?oc=5", "source_name": "Traders Union", "published_at": "2026-06-19T07:00:00+00:00", "published_display": "19 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen (BIIB) Stock Could Be 10.3% Undervalued on Its Pipeline Narrative", "summary": "", "url": "https://news.google.com/rss/articles/CBMilgFBVV95cUxNdVlTVFE5VWtlZDZCV1lvVU5sMzV5QUc1UW8tMEFITTR6SkxKZmpSYjVWaXpaeHNNLXJFcXVpeGpiVXhOZXBHQlZVZlNJMXR1UFFLYW9mUG9jajJUZXE4cWhybGZ6Nm1DZ0x2ZVFEb0d2eFByWTl5VUZicTN4SVlhVWdpdmNGZE5WYXRqRDYwU3FUWUdReXc?oc=5", "source_name": "Market source", "published_at": "2026-06-19T07:00:00+00:00", "published_display": "19 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen Completes Acquisition of Apellis Pharmaceuticals", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxOZ256enZtNjcySFlVRFVBdlVmVlIxLVFUYVZGVVJCMWJyaEVwaG1XSFdrOWxZU3ZDWGtiZmVUNkRtSmtKeTIyaldoQ2xuQ3JzaXdQeUNteGZOM3hZYzI5UUJ0MXVYNDBjVGZrSldQQUFSaF9MUUphR1lyX3daMl9pODJkdGU1NWRLM0NLRDlvelJmOEkzYV92VkY1TE1qWEFXV3dyWW1FeGJObnowT0VfUlRISFR0YXc?oc=5", "source_name": "Biogen", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen to Share New SMA Data at Muscular Dystrophy Association and SMA Europe Conferences", "summary": "", "url": "https://news.google.com/rss/articles/CBMixwFBVV95cUxNRWZUUFdGSnJzeUhKM19mMGtuODF6NW11UTNfYTV2amdxT25zR1VQWlIyLVhtTUswV1VOWDR4cUNPRUFPdkJvOGo0cWxRUjBNN2NOaDg2Nk9UYlRseUVwWnkwWmpnNUFsMUVhOXYtcEtGRHM5MlJOVjhTYnJRX1NuQWxTX282ZDQ4Q0t2TVJJbTFYZ09fT2NYeG5pUVZiVzVLS2xwMldxWnBjTVFEZnF4aTlna0lMbUJ1N1FLWHRRYXhaalNNel93?oc=5", "source_name": "Biogen", "published_at": "2026-03-05T12:32:19+00:00", "published_display": "05 Mar 2026 12:32", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen and Stoke Therapeutics Enter into Collaboration to Develop and Commercialize Zorevunersen for the Treatment of Dravet Syndrome, a Rare Genetic Epilepsy Associated with Refractory Seizures and Neurodevelopmental Impairments", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxNVUxBUmhVNXg4eEJUeXFYeW0yMjNDSWxRSktnMzRjTldpbHVWYm1Oa3pFZUthbmtzWi1mZDFaY1dzWXhFQ3RQZkc2TWNTLTMxd1hEZmQ5MlBNWHl2ZzhINHdIanE1c2RxZi0yTEdxd2NRUUJjSms3bDF2WXpTUllPN3p5T3MwOWZKcGpFdkZ3MEpCUTdyeHRQUG9lYk1wWFVmTnJBYWNNTTNOVUE5MXZnYVNNc21lVXFBM2dqeTB4SDdEeUU?oc=5", "source_name": "Biogen", "published_at": "2025-02-18T08:00:00+00:00", "published_display": "18 Feb 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen to Acquire Reata Pharmaceuticals", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxPLW5Vbmd0c1FZbTd4MzduTnlKa19DS0tNRzlBRjlxMGhqdlhkNm5XUGFTcExGS2JDcHQyTmtQNk5OOGFIYkF5RFFwbXNOSWhRNmh2eW44TzhBNXdRZlVLOUZrb2p6c0VDQ2hqQzZvbUlQOFVCejRsNEd3MXpmQVlMcExFT3NtdnB1cFJjZDRBdTEwa2Y5c1ZLTURlczJFbVJaQVE?oc=5", "source_name": "Biogen", "published_at": "2023-07-28T07:00:00+00:00", "published_display": "28 Jul 2023 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen Stock Trading Halted Today; FDA Advisory Committee to Review Supplemental Biologics License Application for the Potential Traditional Approval of LEQEMBI in Early Alzheimer\u2019s Disease", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxQTUlIb3NucjNtT2VWMkdlUWJPS2I5cDdGVk00LVNJaUxmcTdBd3dFU0VmeENPMlhDdzZWYWwxSGlOQXNpd3QtLVlpNW1jcFlyR1pVekRkLTdyT2VLX1BrdmRRdncxNXRsM0QxVWxyb3RldlZZMm1YTUpaVndtbWtITjBmRU9ZOGRtaG5SSUQwYjRpR0RUQjU2NWZDQmdMZFk1MEVRUnVqclQ2TTdLTnFXT3htODNEQmx2bjhaTHNvMWxuS002SXc?oc=5", "source_name": "Biogen", "published_at": "2023-06-09T07:00:00+00:00", "published_display": "09 Jun 2023 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen Inc.: Target Price Consensus and Analysts Recommendations | BIIB | US09062X1037", "summary": "", "url": "https://news.google.com/rss/articles/CBMieEFVX3lxTFA4SXprREh2SUdHaGpxR2JjWEFfQl8ySUZKd0dVZ0pEWXpyc0xiU1lLMlRWMzlsTGFsZUdOaXptS2dURElhc2kxcHkzNzJmcXh5Zy1IMDJSQ20tLXotSnJ2elRYcUZGclViNHdwNXhuZDlyRGR0UnlOYw?oc=5", "source_name": "marketscreener.com", "published_at": "2020-08-18T17:42:07+00:00", "published_display": "18 Aug 2020 17:42", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen\u2019s Board of Directors Approves Separation of Bioverativ and Declares Special Dividend Distribution of Bioverativ Stock", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxNZXh4dlJwdnhYS3pNay02VWZaYXNqbm1Lamx2NFIxbVhPelI3WVNzeVJJa3RJZU45UllHYUhjMGtqcmgyMUZzZ0pkRzJlVFlOTTl2WVNzcjVfb3JGcnAyWWpSODg4dFUyMmthZU1xMGdJWlAxRWhISzgtZDVIaGRRc1Q0cHhBeHJJYVJURThvQlV0RV8yWmh4QjluN3ZEZnNNeXhvR3BScy1kSnR5UmN0Vk93S3ljek5scmY2ZkV5TQ?oc=5", "source_name": "Biogen", "published_at": "2019-06-12T10:45:37+00:00", "published_display": "12 Jun 2019 10:45", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen Inc (BIIB) Stock Price, Trades & News", "summary": "", "url": "https://news.google.com/rss/articles/CBMiV0FVX3lxTE1ncXJveXZYNmh6cWN1RXNLQXdoNVdoLTluTnhOb0lWbHVVdWZxVWx0OTRkZzVkczRNbFBJUEg1VF85dC1iYVhUazBsVVZfRkV0Q25tenF0RQ?oc=5", "source_name": "GuruFocus", "published_at": "2019-04-15T16:19:17+00:00", "published_display": "15 Apr 2019 16:19", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen Completes Separation of Global Hemophilia Business, Bioverativ", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxOc1o0UnRZTHRidWIzVGxrNThyZE95WXVtUXVOUVlLT2dQV3hPaG4ta2hzTm1qX1lBZTZyRmRnTmxNaDN6eWdkVExWVVNFMWo2eVZULTdTMHBXUW45Tnd3YkQwdmpJc0VkWUFuRHQ3TzJDNDZJNlZ0Y25HazZVVXludWY0aUgtWWxPQ3h4dWIyNjR0a2V1MTM4RDh0b1JZQW1qU254X0txeDJjZlo3Y0twQXN0dFk4SDVnLWc?oc=5", "source_name": "Biogen", "published_at": "2017-02-01T08:00:00+00:00", "published_display": "01 Feb 2017 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Biogen Shares Decline After Detailed Diranersen Alzheimer's Study Data", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxOVVR5dEN4SnN0MHpFOGNsMUZzWmhwWXpidnl5c0N1c1lTaWNoNTBoeGFNMjZzZ1dfZXdoME5GOUM2eW5SdENiRTVDVElCeG5ZUkJ0NTN4S3plWXhHQ3dHZDRZa0hBdEVtVmlTc0wyS1dhNnVSbFBiZXRJNng4NFBzQWV5ai1SRTg1SUJDaWJNdnQ5NVVv?oc=5", "source_name": "Yahoo! Finance Canada", "published_at": "2026-07-15T14:51:00+00:00", "published_display": "15 Jul 2026 14:51", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen's incoming legal chief has 20 years in biotech leadership", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxOUnRIeGp1NHc0X0U4U29lRGp5UHZBMUJ5NWJIamVEZVNfUjMtZ2FFUHROM0Z3ZlZIajZ1OUh3dXFQZDRkcERVRDJYVnhfYWp2cnNDTVotVE1wdW1BQkhTUk1PV3l2bzQ2akZLSThnVGhfZEY3WnRtRGkzNmUzZ296cE1zRS0wQ2MyZ0Z6QUNxZWpSTG5uelBqc0xVVkpsak9qdzRJNw?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-15T12:15:00+00:00", "published_display": "15 Jul 2026 12:15", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AAIC26: Biogen stock drops after unveiling tau-targeting ASO data", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxPQWRsTVNULWt1Y2Q0RVFPNmktOFFFLXhiYkdyeGJLeTBMcDhwMVViMnNjbWFzbF9Yc3lfTnVnVENFeVc4cjNzSmhYMTVsX1lTcFoyNTNVd19YY1BKZDRZSlVJOXdtVEs1dVBSNFY2aUR4R21nY0ZIT0k5a1MzTmIxM0dHbWxTMGRsVmdvWVBkVjhSdE5kbU93UDRuWl9BZXBBNS0tLXdOTHNtdw?oc=5", "source_name": "Clinical Trials Arena", "published_at": "2026-07-15T10:38:07+00:00", "published_display": "15 Jul 2026 10:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen (BIIB) Following Fresh Alzheimer\u2019s Data Is The Upside Story Still Intact", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxONk5GX0ZoNHhUVFNpb0hlRmEyRHY1UC1xUjl2ZFBidUxKNW1zTTRJckdsbzlDMU5VNlNkcHdKM19KcURzMzRDZzU1enJTcEo2ckJRTjhpSERaVmlVWmFYeWlOWVBFSXU5ZFFoSHBCZzhlLXNqYmNKUVBqN2cyQWx1RmdaZmJ3dWhFU3NoZUFfeVFYek5IM3NTS0cxaTRtaGphTl9BVw?oc=5", "source_name": "Market source", "published_at": "2026-07-15T02:11:00+00:00", "published_display": "15 Jul 2026 02:11", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen Dips As Questions Weigh On Alzheimer's 'Breakthrough'", "summary": "", "url": "https://news.google.com/rss/articles/CBMilgFBVV95cUxPVDB3YXIwcWpmMUpkUGJ4bGhQQ05HWjJIZi16RmFLeEN3UW1nTmhmV2RVUjdmWko0VWhwaGlqYXpHbjU2RzdndUdiN2R5UVVxc1VoRXU4YWs1SDZSQnhHUGQyem1xalZiX2RxcGtMU3M4aE9SMnhQQktNMGU4Q2pqRmxPbERDdTYzMC1Bc1hyYklQSGJHNFE?oc=5", "source_name": "Investor's Business Daily", "published_at": "2026-07-14T20:13:00+00:00", "published_display": "14 Jul 2026 20:13", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen\u2019s Alzheimer\u2019s Drug Leaves Questions Unanswered, and That\u2019s a Problem", "summary": "", "url": "https://news.google.com/rss/articles/CBMiekFVX3lxTFA3VFNGa2ZadVdpZmNTSkdPcy1IdUR3Rl9SOHhEM1VRbTJsVFdfUi1EdUw1Z2IyZ1JyTWtGa0ZZTFU2b3ZueTlISU83NXFReDkwMWVvN2Q5REJKRjdoSUVFc2tNUDg2Y29sWVpCbzVRVXJCb3JhdmhvLVZ3?oc=5", "source_name": "Barron's", "published_at": "2026-07-14T18:09:00+00:00", "published_display": "14 Jul 2026 18:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen defends anti-tau drug after stock slides on Alzheimer\u2019s readout", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxNSW45Q216RDR0VU1LTmgzRXF2M1BEdVExcGZhVDBDWlQzNHVVLXpNYmRtRHFGZkJPZGJxc3gzQkpQSzE1eldnUE5xdGUyMkE4RkxvdEl6aHBfNFMweUV5RTI5OWNzcHNzQUNWNGJLaTRyZllYblBJQmQtZzUzVzh3YWF5Ry1xSjV5azhfNmhoREdVdk8wRk8zaFZTZTZIRUk2Mm5IeUYyYw?oc=5", "source_name": "Fierce Biotech", "published_at": "2026-07-14T18:00:18+00:00", "published_display": "14 Jul 2026 18:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen stock falls 8% on Alzheimer's drug diranersen trial data", "summary": "", "url": "https://news.google.com/rss/articles/CBMifEFVX3lxTE4yZE1lckJXYnZXWjd0T2FvU0h6LWNRcEZMUXgtOFRkYktxRFg4NVJqYTJxMjk1eE81b0Z4dW83cDFLN2Fsa1lFLWQ2Q0JHdmg3R0pjZng3a1p2YWZOR0pmSVQwT1N5dHNrbkVkeEMtTnJXalhGUVQ3RlFvMUM?oc=5", "source_name": "qz.com", "published_at": "2026-07-14T17:42:38+00:00", "published_display": "14 Jul 2026 17:42", "sentiment": "negative", "sentiment_pct": 22, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen slides as investors reassess Alzheimer\u2019s data and earnings overhang", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxQZzdxemtVY2FSQXpyalFTX1YxaVpEUE9BOGpvR2xQN2MtcXRrcVQ4eVRLcjE3eXZfd05WRTd2aWxtMlQ2R3ZwVUczWm1VcnFEdnlfX3ZvNEpfNk56Y19BaWlGNnhubmV2TVdTZXNCQ3BHdHFSdEh5R1FFRzNWY29IUWxZMXJlM0JiUHNVMnNxcVdXVWxPSE50ZVpzVHVIanJEMXZfd0dBcE9IeTJUcElOWVhMdkdmUQ?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-07-14T14:51:00+00:00", "published_display": "14 Jul 2026 14:51", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How Investors Are Reacting To Biogen (BIIB) At-Home LEQEMBI Autoinjector Approval", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOVUZIWjNnSWJNTFFlaGlKTmh2LVp5ZjlSM0t0TE1ORFVjYVFXalN0V2NuWEIxcHNfMXllbFpNeDFTeVBVWmZTQ1pGUFhnV3M5R01GbU80NFRCdVlaQVJHcUtlNUkyYXlhRmJEdGxpaG9pRGVNZ1V0czUycE9JWmU0M3BDRml0N1VZNlJoSGhxR2VmWmlWS0EtalUtbVI?oc=5", "source_name": "Market source", "published_at": "2026-07-14T14:14:39+00:00", "published_display": "14 Jul 2026 14:14", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen Shares Rise After Positive Phase 2 Alzheimer\u2019s Trial Results (BIIB)", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxQLWpoTm14djJ1V2JHV1hxQlNoZUwtRjV0V2pOOFBIb2haNEU4TW5QdUg5TUhQb180bWxFczdYcWZScHF2Yk4zVHVIYUlIY3Q2Y2VHamJQWnl6QVh1YnVvb2JUNXFvSW4taTRvWl9jR3BMY0JiRjNYQWMyT3VSUnBhSkl5S05TeUhteTdialVBdl9CbFF3b0ZxVkxR?oc=5", "source_name": "Market source", "published_at": "2026-07-14T13:48:37+00:00", "published_display": "14 Jul 2026 13:48", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen Stock Is Upgraded to Buy Ahead of Key Alzheimer\u2019s Drug Study Details", "summary": "", "url": "https://news.google.com/rss/articles/CBMigwFBVV95cUxONlozWDZQcXFxdjFmVEJvWEE2M0p4OUFKX2FsOEFSalB1RnRsVXFxa0dSenNGMmFaMzQxakRFQVB0eERMXzU4UlVpNkQ1WWRzc0hDZk9WQ1o4NkhlUlBhUVZkMm85Wl9TMGM2T3lCeEdUekVJUHZ0Z2t5WGh3V0FqRjgzbw?oc=5", "source_name": "Barron's", "published_at": "2026-07-13T18:32:00+00:00", "published_display": "13 Jul 2026 18:32", "sentiment": "positive", "sentiment_pct": 84, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Here is Why Biogen (BIIB) is One of the Most Undervalued NASDAQ Stocks to Buy Right Now", "summary": "", "url": "https://news.google.com/rss/articles/CBMikwFBVV95cUxNR1huQlhQV3dTUFFGeXMxMFBOVkc3aXhaYUhscUhUdE9UQTRSVk9CNGtDRGFhcTQyYlowbXdiNUR2RGdDczNMZXdwblR5OFdNNk04cjRLUkR3cXN4MXhKVG1RWXYtT1NTb2V6d2JiMzF6dndGX194alkwZGw4UjdubUxkWXpuM0E1MEZIVXo3SlFvWlE?oc=5", "source_name": "Market source", "published_at": "2026-07-05T07:00:00+00:00", "published_display": "05 Jul 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Biogen (BIIB) Stock Is Up Today", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxPbmNGeFAtenBxazFmYWJoYzFSd2tSRDRHa3J2S1F6SVdKRkFxTzY1WlFxeFg0TV9VYzBBdk54MmtBUFhNY211enhVSGUxeTczMURlUEktTmVpLUVDUUFDRzNBT2pWUFdVRUlCT3U0VHVfYjMxZUs1bW4xeWJTU2hXUURrTG9EaGdnbGU4N0hJNHVxb3l5UUFn?oc=5", "source_name": "Market source", "published_at": "2026-06-26T07:00:00+00:00", "published_display": "26 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen stock price forecast: $174.41 support comes into view as BIIB slips 1.94%", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxQamVtNDJibjVtbWNGNEdPWG1QajFFcUR6cmlUYWNRWmQzUnRaMHd2WFNmYlZDSGN0b011SHlqUG1rN25sSmlfWTRTeXM0Q1RHTXVBZGtMbC1ab1NOSGRvdlp4VlJrMjU0ZUFObTlTMFM4SVlxbjZYSFVycFlpOFlRb2R6d0lac2pXTHE2T3RwRmlOOEp5cGNCTnZfeExudw?oc=5", "source_name": "Traders Union", "published_at": "2026-06-19T07:00:00+00:00", "published_display": "19 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen (BIIB) Stock Could Be 10.3% Undervalued on Its Pipeline Narrative", "summary": "", "url": "https://news.google.com/rss/articles/CBMilgFBVV95cUxNdVlTVFE5VWtlZDZCV1lvVU5sMzV5QUc1UW8tMEFITTR6SkxKZmpSYjVWaXpaeHNNLXJFcXVpeGpiVXhOZXBHQlZVZlNJMXR1UFFLYW9mUG9jajJUZXE4cWhybGZ6Nm1DZ0x2ZVFEb0d2eFByWTl5VUZicTN4SVlhVWdpdmNGZE5WYXRqRDYwU3FUWUdReXc?oc=5", "source_name": "Market source", "published_at": "2026-06-19T07:00:00+00:00", "published_display": "19 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen Completes Acquisition of Apellis Pharmaceuticals", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxOZ256enZtNjcySFlVRFVBdlVmVlIxLVFUYVZGVVJCMWJyaEVwaG1XSFdrOWxZU3ZDWGtiZmVUNkRtSmtKeTIyaldoQ2xuQ3JzaXdQeUNteGZOM3hZYzI5UUJ0MXVYNDBjVGZrSldQQUFSaF9MUUphR1lyX3daMl9pODJkdGU1NWRLM0NLRDlvelJmOEkzYV92VkY1TE1qWEFXV3dyWW1FeGJObnowT0VfUlRISFR0YXc?oc=5", "source_name": "Biogen", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen to Share New SMA Data at Muscular Dystrophy Association and SMA Europe Conferences", "summary": "", "url": "https://news.google.com/rss/articles/CBMixwFBVV95cUxNRWZUUFdGSnJzeUhKM19mMGtuODF6NW11UTNfYTV2amdxT25zR1VQWlIyLVhtTUswV1VOWDR4cUNPRUFPdkJvOGo0cWxRUjBNN2NOaDg2Nk9UYlRseUVwWnkwWmpnNUFsMUVhOXYtcEtGRHM5MlJOVjhTYnJRX1NuQWxTX282ZDQ4Q0t2TVJJbTFYZ09fT2NYeG5pUVZiVzVLS2xwMldxWnBjTVFEZnF4aTlna0lMbUJ1N1FLWHRRYXhaalNNel93?oc=5", "source_name": "Biogen", "published_at": "2026-03-05T12:32:19+00:00", "published_display": "05 Mar 2026 12:32", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen and Stoke Therapeutics Enter into Collaboration to Develop and Commercialize Zorevunersen for the Treatment of Dravet Syndrome, a Rare Genetic Epilepsy Associated with Refractory Seizures and Neurodevelopmental Impairments", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxNVUxBUmhVNXg4eEJUeXFYeW0yMjNDSWxRSktnMzRjTldpbHVWYm1Oa3pFZUthbmtzWi1mZDFaY1dzWXhFQ3RQZkc2TWNTLTMxd1hEZmQ5MlBNWHl2ZzhINHdIanE1c2RxZi0yTEdxd2NRUUJjSms3bDF2WXpTUllPN3p5T3MwOWZKcGpFdkZ3MEpCUTdyeHRQUG9lYk1wWFVmTnJBYWNNTTNOVUE5MXZnYVNNc21lVXFBM2dqeTB4SDdEeUU?oc=5", "source_name": "Biogen", "published_at": "2025-02-18T08:00:00+00:00", "published_display": "18 Feb 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen to Acquire Reata Pharmaceuticals", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxPLW5Vbmd0c1FZbTd4MzduTnlKa19DS0tNRzlBRjlxMGhqdlhkNm5XUGFTcExGS2JDcHQyTmtQNk5OOGFIYkF5RFFwbXNOSWhRNmh2eW44TzhBNXdRZlVLOUZrb2p6c0VDQ2hqQzZvbUlQOFVCejRsNEd3MXpmQVlMcExFT3NtdnB1cFJjZDRBdTEwa2Y5c1ZLTURlczJFbVJaQVE?oc=5", "source_name": "Biogen", "published_at": "2023-07-28T07:00:00+00:00", "published_display": "28 Jul 2023 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen Stock Trading Halted Today; FDA Advisory Committee to Review Supplemental Biologics License Application for the Potential Traditional Approval of LEQEMBI in Early Alzheimer\u2019s Disease", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxQTUlIb3NucjNtT2VWMkdlUWJPS2I5cDdGVk00LVNJaUxmcTdBd3dFU0VmeENPMlhDdzZWYWwxSGlOQXNpd3QtLVlpNW1jcFlyR1pVekRkLTdyT2VLX1BrdmRRdncxNXRsM0QxVWxyb3RldlZZMm1YTUpaVndtbWtITjBmRU9ZOGRtaG5SSUQwYjRpR0RUQjU2NWZDQmdMZFk1MEVRUnVqclQ2TTdLTnFXT3htODNEQmx2bjhaTHNvMWxuS002SXc?oc=5", "source_name": "Biogen", "published_at": "2023-06-09T07:00:00+00:00", "published_display": "09 Jun 2023 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen Inc.: Target Price Consensus and Analysts Recommendations | BIIB | US09062X1037", "summary": "", "url": "https://news.google.com/rss/articles/CBMieEFVX3lxTFA4SXprREh2SUdHaGpxR2JjWEFfQl8ySUZKd0dVZ0pEWXpyc0xiU1lLMlRWMzlsTGFsZUdOaXptS2dURElhc2kxcHkzNzJmcXh5Zy1IMDJSQ20tLXotSnJ2elRYcUZGclViNHdwNXhuZDlyRGR0UnlOYw?oc=5", "source_name": "marketscreener.com", "published_at": "2020-08-18T17:42:07+00:00", "published_display": "18 Aug 2020 17:42", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen\u2019s Board of Directors Approves Separation of Bioverativ and Declares Special Dividend Distribution of Bioverativ Stock", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxNZXh4dlJwdnhYS3pNay02VWZaYXNqbm1Lamx2NFIxbVhPelI3WVNzeVJJa3RJZU45UllHYUhjMGtqcmgyMUZzZ0pkRzJlVFlOTTl2WVNzcjVfb3JGcnAyWWpSODg4dFUyMmthZU1xMGdJWlAxRWhISzgtZDVIaGRRc1Q0cHhBeHJJYVJURThvQlV0RV8yWmh4QjluN3ZEZnNNeXhvR3BScy1kSnR5UmN0Vk93S3ljek5scmY2ZkV5TQ?oc=5", "source_name": "Biogen", "published_at": "2019-06-12T10:45:37+00:00", "published_display": "12 Jun 2019 10:45", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen Inc (BIIB) Stock Price, Trades & News", "summary": "", "url": "https://news.google.com/rss/articles/CBMiV0FVX3lxTE1ncXJveXZYNmh6cWN1RXNLQXdoNVdoLTluTnhOb0lWbHVVdWZxVWx0OTRkZzVkczRNbFBJUEg1VF85dC1iYVhUazBsVVZfRkV0Q25tenF0RQ?oc=5", "source_name": "GuruFocus", "published_at": "2019-04-15T16:19:17+00:00", "published_display": "15 Apr 2019 16:19", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biogen Completes Separation of Global Hemophilia Business, Bioverativ", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxOc1o0UnRZTHRidWIzVGxrNThyZE95WXVtUXVOUVlLT2dQV3hPaG4ta2hzTm1qX1lBZTZyRmRnTmxNaDN6eWdkVExWVVNFMWo2eVZULTdTMHBXUW45Tnd3YkQwdmpJc0VkWUFuRHQ3TzJDNDZJNlZ0Y25HazZVVXludWY0aUgtWWxPQ3h4dWIyNjR0a2V1MTM4RDh0b1JZQW1qU254X0txeDJjZlo3Y0twQXN0dFk4SDVnLWc?oc=5", "source_name": "Biogen", "published_at": "2017-02-01T08:00:00+00:00", "published_display": "01 Feb 2017 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 80, "total_relevant": 25, "sentiment_summary": {"positive": 4, "negative": 2, "neutral": 19, "score": 52, "total": 25, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 82, "events": [{"event": "general", "label": "Market update", "weight": 9.15, "count": 16}, {"event": "analyst", "label": "Analyst action", "weight": 1.45, "count": 2}, {"event": "earnings", "label": "Earnings", "weight": 1.1, "count": 2}, {"event": "regulatory", "label": "Regulatory and legal", "weight": 1.1, "count": 2}, {"event": "guidance", "label": "Guidance", "weight": 0.55, "count": 1}, {"event": "deals", "label": "Deals and strategy", "weight": 0.55, "count": 1}], "positive_events": 4, "negative_events": 2}, "market_context": {"has_market_context": true, "latest_close": 172.66, "latest_week": "2026-07-10", "one_week_move": -8.1, "four_week_move": -1.0, "twelve_week_move": 15.0, "trend_signal": "1", "trend_label": "Trend active", "trend_tone": "positive", "market_dynamics": 0.766829, "market_dynamics_buy_signal": false, "relative_strength": -3.553308, "fair_value_gap": 1.2, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "positive", "expectation_probability": 55.8566, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-8.1% over one week, -1.0% over four weeks, trend active, and near fair-value range."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "negative", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 61, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Biogen", "count": 7}, {"label": "Market source", "count": 6}, {"label": "Barron's", "count": 2}, {"label": "Yahoo! Finance Canada", "count": 1}, {"label": "Stock Titan", "count": 1}, {"label": "Clinical Trials Arena", "count": 1}, {"label": "Investor's Business Daily", "count": 1}, {"label": "Fierce Biotech", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 25}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 16}, {"label": "Earnings", "count": 2}, {"label": "Regulatory and legal", "count": 2}, {"label": "Analyst action", "count": 2}, {"label": "Guidance", "count": 1}, {"label": "Deals and strategy", "count": 1}, {"label": "Capital return", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "52/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "negative", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "82/100 classification confidence."}, {"label": "Company focus", "value": "25", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "2", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend active", "tone": "positive", "text": "-8.1% over one week, -1.0% over four weeks, trend active, and near fair-value range."}, {"label": "Latest direct headline", "value": "Negative", "tone": "negative", "text": "Biogen Shares Decline After Detailed Diranersen Alzheimer's Study Data"}], "updated_at": "2026-07-18T02:31:25.757981+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}